Press releases
- Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System - the World's First Robotic Assistant for Shoulder Replacement Surgery
- Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024
- Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity
- Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting
- Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results
- Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2023 Financial Results
- Zimmer Biomet Announces Appointment of Louis A. Shapiro to Board of Directors
More ▼
Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 132.06 |
Average volume | -- |
---|---|
Shares outstanding | 205.08m |
Free float | 204.83m |
P/E (TTM) | 27.13 |
Market cap | 27.20bn USD |
EPS (TTM) | 4.89 USD |
Annual div (ADY) | 0.8678 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Mar 26 2024 |
Div pay-date | Apr 30 2024 |
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼